Anti-emetics are typically prescribed before, during, and after cancer treatments known to cause nausea and vomiting. The timing and type of anti-emetic depend on the emetic risk of the treatment, which is categorized as high, moderate, low, or minimal. For high-risk treatments, a combination of anti-emetics is often used to maximize efficacy.
